» Articles » PMID: 28392175

Structural Basis of Mycobacterium Tuberculosis Transcription and Transcription Inhibition

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2017 Apr 11
PMID 28392175
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, which kills 1.8 million annually. Mtb RNA polymerase (RNAP) is the target of the first-line antituberculosis drug rifampin (Rif). We report crystal structures of Mtb RNAP, alone and in complex with Rif, at 3.8-4.4 Å resolution. The results identify an Mtb-specific structural module of Mtb RNAP and establish that Rif functions by a steric-occlusion mechanism that prevents extension of RNA. We also report non-Rif-related compounds-Nα-aroyl-N-aryl-phenylalaninamides (AAPs)-that potently and selectively inhibit Mtb RNAP and Mtb growth, and we report crystal structures of Mtb RNAP in complex with AAPs. AAPs bind to a different site on Mtb RNAP than Rif, exhibit no cross-resistance with Rif, function additively when co-administered with Rif, and suppress resistance emergence when co-administered with Rif.

Citing Articles

Regulation of Steady State Ribosomal Transcription in : Intersection of Sigma Subunits, Superhelicity, and Transcription Factors.

Ruiz Manzano A, Jensen D, Galburt E bioRxiv. 2025; .

PMID: 40060575 PMC: 11888270. DOI: 10.1101/2025.02.24.639987.


Pleomorphic effects of three small-molecule inhibitors on transcription elongation by RNA polymerase.

Herrera-Asmat O, Tong A, Lin W, Kong T, Del Valle J, Guerra D bioRxiv. 2025; .

PMID: 39975155 PMC: 11839117. DOI: 10.1101/2025.02.07.637008.


Computational analysis of the effect of a binding protein (RbpA) on the dynamics of Mycobacterium tuberculosis RNA polymerase assembly.

Bheemireddy S, Sowdhamini R, Srinivasan N PLoS One. 2025; 20(1):e0317187.

PMID: 39883746 PMC: 11781615. DOI: 10.1371/journal.pone.0317187.


Structure of a Cyclic Peptide as an Inhibitor of Transcription: NMR and Molecular Dynamics Simulations.

Stephanie F, Tambunan U, Kuczera K, Siahaan T Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598454 PMC: 11597662. DOI: 10.3390/ph17111545.


MoaB2, a newly identified transcription factor, binds to σ in .

Brezovska B, Narasimhan S, Sikova M, Sanderova H, Koval T, Borah N J Bacteriol. 2024; 206(12):e0006624.

PMID: 39499088 PMC: 11656743. DOI: 10.1128/jb.00066-24.


References
1.
Srivastava A, Degen D, Ebright Y, Ebright R . Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus. Antimicrob Agents Chemother. 2012; 56(12):6250-5. PMC: 3497154. DOI: 10.1128/AAC.01060-12. View

2.
Artsimovitch I, Vassylyeva M, Svetlov D, Svetlov V, Perederina A, Igarashi N . Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins. Cell. 2005; 122(3):351-63. DOI: 10.1016/j.cell.2005.07.014. View

3.
Stewart F, Gordon D, Levin B . Fluctuation analysis: the probability distribution of the number of mutants under different conditions. Genetics. 1990; 124(1):175-85. PMC: 1203904. DOI: 10.1093/genetics/124.1.175. View

4.
Jacques J, Rodrigue S, Brzezinski R, Gaudreau L . A recombinant Mycobacterium tuberculosis in vitro transcription system. FEMS Microbiol Lett. 2006; 255(1):140-7. DOI: 10.1111/j.1574-6968.2005.00071.x. View

5.
Artsimovitch I, Chu C, Lynch A, Landick R . A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science. 2003; 302(5645):650-4. DOI: 10.1126/science.1087526. View